1,103
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Hepatic blood volume is decreased in patients with cirrhosis and does not decrease further after a meal like in healthy persons

Pages 1205-1209 | Received 03 Mar 2021, Accepted 04 Jul 2021, Published online: 30 Jul 2021
 

Abstract

Background & Aims

The aim was to measure fractional hepatic blood volume (HBV) and hepatic blood flow (HBF) before and after a meal in patients with cirrhosis (n = 7) and healthy persons (n = 6).

Methods

Catheters were placed in a radial artery and a hepatic vein for blood sampling and a peripheral vein for indocyanine green (ICG) infusion. A 6-min positron emission tomography (PET) liver scan was performed after inhalation of 1000 MBq 15O-CO and repeated after ingestion of a standard meal. HBV was calculated as the 15O-CO concentration in liver tissue (PET) divided by that in arterial blood. HBF was calculated from ICG infusion rate and arterial and hepatic venous blood concentrations according to Fick’s principle.

Results

Mean fasting HBV was 14 mL blood/100 mL liver tissue in patients with cirrhosis and 21 mL blood/100 mL liver tissue in healthy subjects (p < .01). Mean HBV did not change postprandially in patients with cirrhosis (13 mL blood/100 mL liver tissue) but decreased in healthy subjects (17 mL blood/100 mL liver tissue; p = .02). Mean fasting HBF was 1.5 L blood/min in patients with cirrhosis and 1.1 L blood/min in healthy subjects and increased in both groups of subjects to 1.8 L blood/min.

Conclusions

Fasting HBV was lower in patients with cirrhosis and did not decrease postprandially as it did in the healthy controls although the HBF increased equally. Patients with cirrhosis thus have a disturbed hemodynamic response to normo-physiological changes such as a meal.

Author contributions

Study concept, obtained funding, acquisition and analysis of data, statistical analysis, drafting and finishing the manuscript: MS.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The Independent Research Fund Denmark/Medical Sciences [8020-00427B] and The Novo Nordisk Foundation [NNF17OC0029702, NNF20OC0059717].